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Periodontitis in established rheumatoid arthritis
patients: a cross-sectional clinical, microbiological
and serological study
Menke de Smit1*, Johanna Westra2, Arjan Vissink3, Berber Doornbos-van der Meer2, Elisabeth Brouwer2 and
Arie Jan van Winkelhoff1,4
Abstract
Introduction: The association between rheumatoid arthritis (RA) and periodontitis is suggested to be linked to the
periodontal pathogen Porphyromonas gingivalis. Colonization of P. gingivalis in the oral cavity of RA patients has
been scarcely considered. To further explore whether the association between periodontitis and RA is dependent
on P. gingivalis, we compared host immune responses in RA patients with and without periodontitis in relation to
presence of cultivable P. gingivalis in subgingival plaque.
Methods: In 95 RA patients, the periodontal condition was examined using the Dutch Periodontal Screening Index
for treatment needs. Subgingival plaque samples were tested for presence of P. gingivalis by anaerobic culture
technique. IgA, IgG and IgM antibody titers to P. gingivalis were measured by ELISA. Serum and subgingival plaque
measures were compared to a matched control group of non-RA subjects.
Results: A higher prevalence of severe periodontitis was observed in RA patients in comparison to matched non-
RA controls (27% versus 12%, p < 0.001). RA patients with severe periodontitis had higher DAS28 scores than RA
patients with no or moderate periodontitis (p < 0.001), while no differences were seen in IgM-RF or ACPA
reactivity. Furthermore, RA patients with severe periodontitis had higher IgG- and IgM-anti P. gingivalis titers than
non-RA controls with severe periodontitis (p < 0.01 resp. p < 0.05), although subgingival occurrence of P. gingivalis
was not different.
Conclusions: Severity of periodontitis is related to severity of RA. RA patients with severe periodontitis have a
more robust antibody response against P. gingivalis than non-RA controls, but not all RA patients have cultivable
P. gingivalis.
Introduction
Several studies have demonstrated an increased preva-
lence of periodontitis and a higher rate of tooth loss in
patients with rheumatoid arthritis (RA) in comparison
with the general population in the US [1,2], Northern
Europe [3-6], and Australia [7]. RA may also be more
prevalent among patients with periodontitis [4,8]. Differ-
ences in disease criteria and methods for evaluation of
periodontal status, however, form a problem in interpre-
tation of the literature [9,10].
Periodontitis and RA are both chronic destructive
inflammatory disorders and result from deregulation of
the host inflammatory response. Both conditions are
potentiated by an exaggerated inflammatory response
featuring an increase in local and perhaps circulating
pro-inflammatory mediators, resulting in destruction of
the soft and hard tissues surrounding the teeth (the per-
iodontium) and the synovial joint [11-14]. Susceptibility
is influenced by shared genetic and lifestyle factors. Both
diseases are cumulative; that is, severity and loss of
function increase with longer disease duration.
There are a number of postulated mechanisms by
which infections can trigger autoimmune disease, but
most evidence in animal models supports the idea that
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cross-reactive immune responses cause autoimmunity
because of molecular mimicry between microbiological
and self-antigens [15]. Rosenstein and colleagues [16]
have hypothesized that Porphyromonas gingivalis, a
major periodontal pathogen, plays a role in the pathogen-
esis of RA. P. gingivalis is a prokaryote that uniquely con-
tains a peptidyl arginine deiminase enzyme [17] necessary
for citrullination and can induce an immune response to
citrullinated self-proteins [16,18]. Citrullination changes
the structure and function of proteins and has been
demonstrated in several physiological and pathological
processes [19]. Antibodies against citrullinated proteins
(ACPAs) are 95% specific and 68% sensitive for RA
[20,21]. These antibodies can be present several years
before the clinical onset of RA [22] and are associated
with a more destructive disease course than RA without
detectable ACPAs [23]. Moreover, periodontitis can con-
tribute to the total inflammatory burden by eliciting bac-
teremia and systemic inflammatory responses [24,25].
Given the observed epidemiological association and the
hypotheses mentioned above, periodontitis may be
regarded as a risk factor for initiation and progression of
RA. At present, disease management of RA is based on
early diagnosis, aggressive treatment, and regular moni-
toring, and disease remission is the ultimate treatment
goal. To achieve this goal, reduction of total inflamma-
tory burden is necessary. This may involve periodontal
infection control in patients with periodontitis.
Studies have reported higher antibody titers against
P. gingivalis in RA patients and a positive correlation with
ACPAs [26-28], suggesting that infection with this period-
ontal pathogen may play a role in the risk and progression
of RA. However, oral colonization by P. gingivalis in
patients with RA is barely considered. To study whether
the association between periodontitis and RA is dependent
on P. gingivalis, we compared host immune responses in
RA patients with or without periodontitis in relation to
the presence of cultivable P. gingivalis from subgingival
plaque. Because of the recent observation that the
inflamed periodontium contains citrullinated proteins
[29], we also investigated the presence of ACPAs in the
inflammatory exudates from the gingival crevice (gingival
crevicular fluid, or GCF).
Materials and methods
Patients
Patients with rheumatoid arthritis
Established RA patients matching the inclusion criteria
were consecutively recruited between March and Sep-
tember 2011 at the outpatient clinic of the Rheumatology
and Clinical Immunology Department of the University
Medical Center Groningen in Groningen. The inclusion
criterion was fulfilling the American College of Rheuma-
tology classification criteria for RA [30], and exclusion
criteria were age under 18 years, edentulism, diabetes,
active thyroid disease, presence of non-oral infections,
present malignancy, myocardial infarction or stroke
fewer than 6 months prior to the study, pregnancy
including a 6-month post-partum period as well as
breastfeeding and antibiotic use fewer than 3 months
prior to the study. Assuming that the prevalence of peri-
odontitis is 10% to 15% [31] and the odds ratio of period-
ontitis in RA is 1.8 to 2.0 [1,7], we calculated that we
needed a minimum sample size of 75 patients with RA to
find a difference of 12.5% in the prevalence of periodonti-
tis by using a two-sided binomial test.
Non-rheumatoid arthritis controls
As a reference group for microbiological and serological
measurements, subjects without RA were recruited from
among subjects planned for first consultation at the
Department of Dentistry and Oral Hygiene of the Uni-
versity Medical Center Groningen. The procedures of
recruitment and informed consent were the same as for
patients with RA. The inclusion criterion was not having
RA, and exclusion criteria were the same as mentioned
for patients with RA. Non-RA controls were matched
for age, gender, number of teeth, body mass index
(BMI), and smoking and periodontal status. We aimed
to include matched non-RA controls in a ratio of 2:1
(Table 1). Healthy controls were defined as subjects
without periodontitis and without cultivable subgingival
P. gingivalis.
Control cohort for estimating prevalence of periodontitis in
the general population
The prevalence of periodontitis was assessed in subjects
attending a general dental practice within the referral
area (Clinic for General Dental Practice Solwerd in
Appingedam, The Netherlands). This control population
consisted of 420 age- and gender-matched consecutive
patients in whom the Dutch periodontal screening index
(DPSI) score was assessed during one year (2010). The
DPSI is a validated index based on bleeding on probing,
pocket probing depth, and clinical attachment loss [32].
On the basis of DPSI scores, patients were categorized
as having no periodontitis (A), moderate periodontitis
(B), or severe periodontitis (C). Assessment of the socio-
economic status of this group was made according to
data of highest self-reported level of received education
of the municipal public health service of the northeast
region of Groningen [33].
Ethics approval
All participants provided written informed consent prior
to study enrollment according to the Declaration of Hel-
sinki (General Assembly October 2008), and this study
was conducted with the approval of the Medical Ethical
Committee of the University Medical Center Groningen
(METc UMCG 2011/010).
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Clinical examination of rheumatoid arthritis
RA disease activity was measured with the Disease
Activity Score 28 joint count (DAS28) [34]. Other para-
meters were disease duration of RA, smoking status
(current, former, or never), BMI, and RA medication,
including steroids and anti-tumor necrosis factor biolo-
gic agents. Assessment of the socioeconomic status was
made according to highest self-reported level of received
education.
Clinical examination of periodontitis
Periodontal condition was examined by using DPSI. The
DPSI score was taken by a periodontist blinded for the
diagnosis of RA. In the general dental practice, the DPSI
score was taken by the dentist at the first visit of the
patient.
Sampling
Peripheral blood and subgingival samples were obtained
from the RA and non-RA controls at the day of clinical
examination. Subgingival samples were taken by using
sterile paper points [35]. Microbiological sampling
included selection of the deepest bleeding periodontal
pocket in each quadrant of the dentition on the basis of
pocket probing depth measurements. If there were no
bleeding periodontal pockets, mesial sites of the first
molars or, in absence of a first molar, the mesial site
from the adjacent anterior tooth in the dental arch was
selected. Sample sites were isolated with cotton rolls, and
supragingival plaque was carefully removed with curettes
and cotton pallets. Subsequently, two paper points were
inserted to the depth of the pocket and left in place for
10 seconds. All paper points per subject were pooled in
reduced transport fluid [36] and processed for microbio-
logical examination immediately after sampling. GCF
samples were collected in the same way. The deepest
non-bleeding site per quadrant was used to collect GCF
to avoid blood contamination of the sample. GCF sam-
ples were discarded for further analysis if they were visi-
bly contaminated with blood. Paper points for the GCF
sample were pooled per subject in phosphate-buffered
saline (PBS) with 1% bovine serum albumin. The paper
points were removed after centrifuging at 28,000 g for 10
minutes, and the supernatant was stored at -20°C until
use.
Laboratory procedures
Serum was investigated for C-reactive protein (CRP)
concentration by enzyme-linked immunosorbent assay
(ELISA) (DuoSet; R&D Systems, Abingdon, UK). IgM-
RF (in international units per milliliter) was measured
by using an in-house validated ELISA (cutoff point for
positivity: 25 U/mL) [37]. Total IgG anti-cyclic citrulli-
nated protein (anti-CCP) antibodies (ACPAs) (in units
per milliliter) were determined by using the Phadia ana-
lyzer (Phadia Laboratory Systems, Phadia AB, Uppsala,
Sweden) with an upper detection limit of 340 U/mL
(cutoff point for positivity: 10 U/mL). Antibody levels to
five synthetic native peptides representing the best-
established auto-antigens in RA [38] (that is, enolase-1
fibrinogen-1, fibrinogen-2, fibrinogen-3, and vimentin-1
and their citrullinated forms) were measured by using
the same ELISA as described by van de Stadt and collea-
gues [39].
Table 1 Characteristics of patients with rheumatoid arthritis (RA), non-RA controls, and healthy controls
Patients with RA Non-RA controls Healthy controls
Number 95 44 36
Female, percentage 68 57 56
Age in years (SD) 56 (11) 54 (9.7) 34 (15)
Current smoker, percentage 23 27 14
Former smoker, percentage 40 43 0
Body mass index 25.8 (4.9) 25.4 (4.4) NA
Number of teeth 23.4 (6.3) 24.2 (4.9) 27.8 (2.9)
RA duration in years (SD) 7.4 (5.9) 0 0
DAS28 (SD) 2.4 (0.93) 0 0
Seropositive for IgM-RF, percentage 53 0 NA
Seropositive for ACPAs, percentage 71 NA NA
Medication for RA, percentage
None 6 100 100
DMARDs 79 0 0
Anti-TNFa 15 0 0
ACPA, anti-citrullinated protein antibody; anti-TNFa, anti-tumor necrosis factor-alpha; DAS28, disease activity score 28 tender and swollen joint count; DMARD,
disease-modifying anti-rheumatic drug; IgM-RF, immunoglobulin M-rheumatoid factor; NA, not assessed; SD, standard deviation.
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IgA, IgG, and IgM antibodies to P. gingivalis were
determined by using an in-house developed ELISA, in
which a pooled lysate of four randomly selected clinical
isolates of P. gingivalis from patients with periodontitis
was used as an antigen. These monocultures were sus-
pended in ice-cold PBS with protease inhibitors (Com-
plete Mini EDTA-free Protease Inhibitor Cocktail
Tablets; Roche Diagnostics, Basel, Switzerland). After
centrifuging and discarding of the supernatant, pellets
were resuspended in an ice-cold lysis buffer containing
non-denaturing detergent (Noninet P-40; Sigma-Aldrich,
St. Louis, MO, USA) and sonicated for 15 minutes (Bior-
uptor Standard sonication device; Diagenode s.a., Liège,
Belgium). Protein concentration was determined by using
the BCA Protein Assay Kit (Pierce Protein Biology Pro-
ducts, Thermo Fisher Scientific, Rockford, IL, USA).
Microtiter plates (Costar 96-Well; Corning, Amsterdam,
The Netherlands) were coated overnight with 1 μg/mL of
antigen. Standard curves were made from protein stan-
dard (N protein-standard SL; Siemens Healthcare Diag-
nostics, Den Haag, The Netherlands) diluted twofold
(highest standard curve values were for 300, 25, and
250 ng/mL for IgA, IgG, and IgM, respectively). For the
standard curves, the following capture antibodies were
used: monoclonal anti-human IgA (1:4,000, clone GA-
112; Sigma-Aldrich, Zwijndrecht, The Netherlands),
monoclonal anti-human IgM (1:10,000, clone MB-11, μ-
chain-specific; Sigma-Aldrich), and goat anti-human IgG
(1:5,000, F(ab’)2 fragment-specific; Jackson ImmunoRe-
search Europe Ltd., Newmarket, UK), respectively. Serum
samples were incubated in fourfold serial dilutions
(1:100, 1:400, 1:1,600, and 1:6,400). Detection of anti-P.
gingivalis antibodies was carried out with horseradish
peroxidase-labeled goat anti-human IgA, mouse anti-
human IgG (Fc fragment-specific, clone JDC-10), and
mouse anti-human IgM (μ-chain-specific, clone SA-DA4;
all from SouthernBiotech, Birmingham, AL, USA) fol-
lowed by color reaction with tetramythylbenzidin and
hydrogen peroxide. Absorbance was read at 450 nm in
an EMax microplate reader and corrected for background
binding, and concentration of antibodies was calculated
by SOFTmax PRO software (Molecular Devices, Sunny-
vale, CA, USA) according to the IgA, IgG, or IgM stan-
dard curves included on each ELISA plate and expressed
in nanograms per milliliter. As an internal control, two
serum samples with a repeatedly high and a low titer
were tested at each plate. The variation coefficients were
22% for IgA, 20% for IgG, and 25% for IgM anti-P. gingi-
valis. Interference of IgM-RF was investigated by spiking
samples with sera with known high titers of RF. Adding
RF had no measurable effect on anti-P. gingivalis titers.
In paired samples of serum and GCF of patients with
RA, the presence of IgG-ACPAs was assessed by using
the anti-CCP2 ELISA (Euro Diagnostica, Nijmegen, The
Netherlands). Because the HLA-DRB1 shared epitope
(SE) is a known genetic risk factor for RA and a possible
genetic risk factor for periodontitis [40], HLA-DRB1-SE-
containing alleles were genotyped from genomic DNA
in the patients with RA. The presence of an RA SE
was analyzed by a polymerase chain reaction-based
sequence-specific oligonucleotide probe hybridization
(SSOP) approach by using a commercial kit (Hologic
Gen-Probe Incorporated, San Diego, CA, USA) and
Luminex xMAP technology (Luminex Corporation,
Austin, TX, USA) in accordance with the instructions of
the manufacturer.
Microbiology
Microbiological samples were processed by using stan-
dard anaerobic culture techniques [41,42]. Paper point
samples were vortexed for 2 minutes, and appropriate
10-fold serial dilutions (100 μL) in PBS were plated on
blood agar plates (Oxoid no. 2; Oxoid Limited, Basing-
stoke, UK), which were supplemented with horse blood
(5% vol/vol), hemin (5 mg/L), and menadione (1 mg/L)
and incubated in 80% N2, 10% H2, and 10% CO2 at 37°C
for up to 14 days. Besides the presence and proportions
of P. gingivalis, those of other established periodontal
pathogens, including Prevotella intermedia, Fusobacter-
ium nucleatum, Parvimonas micra, Tannerella forsythia,
and Campylobacter rectus, were assessed [43]. Identifica-
tion was based on microscopic morphology, Gram reac-
tion, and the production of a set of metabolic enzymes
(API/ID 32; BioMérieux, La Balme Les Grottes, France).
Additional tests for identification included detection of a
trypsin-like activity based on the degradation of benzoyl-
DL-arginine-2-naphthylamide (Sigma-Aldrich) [44].
Finally, the total number of colony-forming units per
sample was determined.
Statistical analysis
Data were analyzed by using GraphPad Prism 4 and
Instat 3 (GraphPad Software, Inc., San Diego, CA, USA).
For group comparisons among two groups, the unpaired
two-tailed t test for variables with normal distribution
and the two-tailed Mann-Whitney test for skewed vari-
ables were used. For group comparisons among three
groups, Kruskal-Wallis one-way analysis of variance was
performed. The Fisher exact test or the chi-squared test
for independence was used to analyze contingency tables.
Significance level a was 0.05.
Results
Patients
Two hundred thirty-nine consecutive patients with RA
were invited to participate in this study. Of the 167
patients who provided written informed consent, 66
patients met at least one of the exclusion criteria. Of the
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101 included patients, six patients were excluded from
analysis because of incomplete data. The final cohort
consisted of 95 patients with RA. In addition, 203 con-
secutive patients were invited to join the control group.
Of this group, 108 dentate persons without RA provided
written informed consent. Twenty-eight of them had to
be expelled on the basis of the exclusion criteria. The
remaining 80 patients served as non-RA controls for
blood and subgingival samples, matched for age, gender,
BMI, and periodontal and smoking status (n = 44), or as
healthy controls (no periodontitis and no cultivable
P. gingivalis, n = 36). Characteristics of the predomi-
nantly (99%) Caucasian patients with RA, non-RA
controls, and the healthy controls are summarized in
Table 1. The general control population for estimating
the prevalence of periodontitis consisted of 420 indivi-
duals matched for age and gender with the patients with
RA (age of 56 ± 5.5 years, and 68% were female). The
socioeconomic status of this group as assessed by the
highest self-reported level of received education was
comparable between the control population and the
patients with RA (low: 27% versus 36%, middle: 37%
versus 30%, and high: 36% versus 34%).
Periodontitis
Forty-three percent of the patients with RA had moder-
ate periodontitis, and 27% had severe periodontitis.
These numbers are significantly higher than, respec-
tively, the 18% and 12% found in the control population
(P < 0.001). Compared with the control population, the
relative risk for having RA and severe periodontitis was
3.7 (95% confidence interval of 2.4 to 5.9) (Table 2).
RA patients with severe periodontitis had significantly
higher DAS28 scores (P < 0.001) than RA patients with
no or moderate periodontitis (Figure 1). CRP levels in RA
patients with severe periodontitis were higher than in RA
patients without periodontitis (marginally significant, P =
0.05). In none of the DPSI categories was there a differ-
ence in DAS28 scores between smokers and non-smo-
kers or former smokers. Also, no difference was found in
RA disease duration, although patients with severe peri-
odontitis were significantly older (P < 0.01). In the con-
trol population, there were no age differences between
the DPSI categories.
Presence of HLA-DRB1 shared epitope in patients with
rheumatoid arthritis
No differences were found in the presence or absence of
the HLA-DRB1-SE in RA patients with no, moderate, or
severe periodontitis (n = 78). In RA patients with no,
moderate, or severe periodontitis, 58%, 66%, and 62%,
respectively, were positive for HLA-DRB1-SE, and 29%,
21%, and 15%, respectively, had two alleles.
Serology
Between RA patients with no, moderate, or severe period-
ontitis, no differences were seen in IgM-RF and ACPA
levels or in reactivity against the citrullinated peptides eno-
lase-1, fibrinogen-1, -2, and -3, and vimentin-1 (Figure 2).
Between RA patients culture-positive or -negative for P.
gingivalis, only reactivity against citrullinated fibrinogen-2
was different; reactivity was higher in P. gingivalis-positive
patients (P < 0.01). A small number of RA patients with
moderate (n = 2) or severe (n = 2) periodontitis and cul-
ture-positive for P. gingivalis had a higher reactivity against
citrullinated a-enolase compared with RA patients without
periodontitis and without subgingival P. gingivalis. This
P. gingivalis culture-positive subgroup also had high
IgM-RF (mean 539 ± 796 U/mL), ACPAs (mean 340 ±
0 U/mL), and anti-P. gingivalis titers (IgM: mean 93 ± 135,
IgG: 190 ± 357, IgA: 61 ± 81 mg/L).
Overall, patients with RA showed higher IgM anti-P.
gingivalis titers compared with non-RA controls (P <
0.05). There were no differences in anti-P. gingivalis
titers between RA patients and non-RA controls with no
or moderate periodontitis; however, RA patients with
severe periodontitis showed both higher IgG and IgM
anti-P. gingivalis titers compared with non-RA controls
with severe periodontitis (P < 0.05) (Figure 3). RA
patients with moderate periodontitis have a less pro-
nounced anti-P. gingivalis response compared with RA
patients with severe periodontitis but a higher one than
non-RA controls with severe periodontitis for IgG (bor-
derline significant, P = 0.06) and IgM (P < 0.05). Both
RA patients and non-RA controls culture-positive for
P. gingivalis showed higher anti-P. gingivalis titers com-
pared with their culture-negative counterparts.
In patients with RA, serum levels of IgM-RF and
ACPAs showed a strong correlation (r = 0.51, P <
Table 2 Prevalence of periodontitis of rheumatoid arthritis patients compared with the age- and gender-matched
control population




P value Relative risk 95% CI
A: No periodontitis, percentage 30 70 < 0.001
B: Moderate periodontitis, percentage 43 18 < 0.001 3.6 2.3-5.5
C: Severe periodontitis, percentage 27 12 < 0.001 3.7 2.4-5.9
CI, confidence interval; DPSI, Dutch periodontal screening index; RA, rheumatoid arthritis.
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0.0001), as did IgG anti-P. gingivalis with IgM anti-P.
gingivalis (r = 0.41, P < 0.0001) and IgA anti-P. gingiva-
lis (r = 0.66, P < 0.0001). Medication used for RA was
not of influence on P. gingivalis titers. In non-RA con-
trols, IgG anti-P. gingivalis only correlated with IgA
anti-P. gingivalis (r = 0.65, P < 0.0001).
In patients with RA, there was a weak but significant
correlation between IgM anti-P. gingivalis and IgM-RF
(r = 0.33, P < 0.01), ACPAs (r = 0.24, P < 0.05), and
the citrullinated peptides fibrinogen-1 (r = 0.27, P <
0.05) and fibrinogen-3 (r = 0.22, P < 0.05). Likewise,
IgG anti-P. gingivalis was correlated with IgM-RF (r =
0.26, P < 0.05). In RA patients with severe periodontitis,
there were no correlations between IgG, IgM, and IgA
anti-P. gingivalis titers and IgM-RF and ACPAs. In
patients with RA, ACPA levels in serum were compar-
able to ACPA levels in paired GCF samples which were
not visibly contaminated with blood (n = 45, r = 0.89,
P < 0.0001) (Figure 4).
Microbiology
The subgingival prevalence of P. gingivalis was not differ-
ent between patients with RA (16%) and non-RA controls
(20%). In both groups, P. gingivalis was infrequently cul-
tured in the absence of periodontitis (6% to 12%). None
of the other identified periodontal pathogens differed in
prevalence between RA patients and non-RA controls
(P. intermedia: 66% versus 73%, T. forsythia: 84% versus
70%, P. micra: 88% versus 89%, F. nucleatum: 100% ver-
sus 95%, and C. rectus: 33% versus 41%). However, the
prevalence of anaerobic Gram-negative rods other than
P. gingivalis and P. intermedia was higher in patients
with RA (27% versus 8%, P < 0.05), as was the total bac-
terial load (in colony-forming units per milliliter) (P <
0.05), notwithstanding the comparable mean probing
pocket depth between RA patients and matched non-RA
controls (4.2 ± 1.0 mm).
Discussion
In this study, we found a significantly increased preva-
lence of periodontitis in RA patients and the highest RA
disease activity in patients with severe periodontitis.
Importantly, serological markers for systemic inflamma-
tion of periodontal origin further substantiated the
connection of the two diseases in terms of higher anti-
body titers against P. gingivalis in RA patients with
severe periodontitis compared with severe periodontitis
patients without RA. These differences cannot be
explained by differences in P. gingivalis colonization,
since the distributions in RA and non-RA patients were
similar.
Given that periodontitis is associated with only mod-
erate elevations of CRP and erythrocyte sedimentation
rate levels [45,46], the higher DAS28 scores observed in
RA patients with periodontitis can only partly be
explained by these higher levels due to periodontitis.
This is the first study that focused on anti-P. gingivalis
titers in RA and non-RA controls, equally distributed in
prevalence of P. gingivalis and periodontitis. We confirm
elevated antibody titers against P. gingivalis in RA
patients as reported in former studies; however, these
studies did not consider the periodontal status or the
microbiology of the patients with RA [27,28]. We found
higher anti-P. gingivalis titers in RA patients compared
with matched non-RA controls in cases of severe peri-
odontitis. No differences in anti-P. gingivalis titers
between these groups were found in cases of moderate
periodontitis; however, RA patients with moderate peri-
odontitis still had higher titers compared with severe
periodontitis patients without RA. RA patients with cul-
tivable P. gingivalis showed the highest anti-P. gingivalis
titers, suggesting that RA amplifies the antibody
response against P. gingivalis and that colonization of
P. gingivalis could have contributed to the elevated titer,
according to the fact that carriage of P. gingivalis is the
strongest determinant of the systemic antibody response
against this periodontal pathogen [47]. An explanation
for the elevated anti-P. gingivalis titers could be a hyper-
inflammatory state of RA patients with periodontitis.
ACPAs directed to citrullinated peptides of P. gingivalis
could be another explanation for the elevated titers.
Lundberg and colleagues [48] showed cross-reactivity of
Figure 1 DAS28 scores and CRP levels in patients with rheumatoid arthritis and no (a), moderate (b), or severe (c) periodontitis. **P <
0.01. CRP, C-reactive protein; DAS28, disease activity score 28 tender and swollen joint count.
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Figure 2 (A) IgM-RF and ACPA reactivity and (B) reactivity against five citrullinated (cit.) peptides in patients with rheumatoid arthritis
and no (a), moderate (b), or severe (c) periodontitis. No significant differences were observed. ΔOD, optical density of the citrullinated form
minus the native form of the peptide; ACPA, anti-citrullinated protein antibody; IgM-RF, immunoglobulin M-rheumatoid factor.
Figure 3 IgA, IgG, and IgM antibody response against Porphyromonas gingivalis in rheumatoid arthritis (RA) patients and non-RA
controls with severe periodontitis as well as in healthy controls (HC). *P < 0.05. Ig, immunoglobulin.
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human ACPAs with bacterial enolase. We found a high
reactivity in a small subgroup of RA patients with peri-
odontitis and culture-positive for P. gingivalis, but over-
all we found a weak correlation between ACPAs and
anti-P. gingivalis titers. Whether anti-P. gingivalis anti-
bodies are directed against the same epitopes as ACPAs
needs further investigation. To consider whether ele-
vated titers are specific for P. gingivalis, antibody titers
to other periodontal bacteria should be assessed.
Little is known about oral colonization by P. gingivalis
in patients with RA. We found no differences in the pre-
sence and proportions of any of the assessed periodontal
pathogens between RA patients and non-RA controls;
however, the prevalence of anaerobic Gram-negative rods
other than P. gingivalis and P. intermedia was higher in
patients with RA. Recently, Scher and colleagues [49]
assessed the complete subgingival microbiota by pyrose-
quencing and detected P. gingivalis more frequently in
recently diagnosed, never-treated RA patients (n = 25) in
comparison with established RA patients or healthy con-
trols; this finding, however, could be explained by the
higher prevalence of severe periodontitis in those
patients.
An association between the presence of periodontitis
and ACPA or IgM-RF levels or both could not be estab-
lished, in contrast to the findings of Dissick and colleagues
[2], nor could we find differences in reactivity to the five
synthetic citrullinated peptides between the DPSI cate-
gories, other than a higher reactivity against citrullinated
peptide fibrinogen-2 in P. gingivalis culture-positive
patients. As epitope spreading is related to RA disease
duration [39], a widespread reactivity to different citrulli-
nated peptides was found in our cohort with a relatively
long disease duration. In future studies, the (temporal)
relation of RA, periodontitis, and antibodies specific for
RA should be performed in periodontitis patients, in non-
treated RA patients, and/or in patients at risk for RA, ide-
ally in a prospective follow-up study.
We found no differences in the presence or absence of
the HLA-DRB1-SE in RA patients with no, moderate, or
severe periodontitis, although this should be interpreted
with some caution because of the small numbers of
patients. The strong correlation between ACPA levels in
serum and GCF, with lower levels in GCF, is suggestive
of diffusion of ACPAs from plasma to GCF. Within the
limitations of the method used in this study, we found
no indication for local ACPA production in the
periodontium.
Conclusions
We confirmed the previously reported disease associa-
tion between RA and periodontitis and the increased
prevalence of periodontitis in patients with RA. In addi-
tion, the severity of periodontitis appeared to be related
to RA disease activity. Furthermore, severity of RA was
not associated with cultivable P. gingivalis in established
RA patients, although anti-P. gingivalis titers were
higher in RA patients with severe periodontitis com-
pared with matched non-RA subjects.
Abbreviations
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